Skip to main content
Top

Current Hypertension Reports

Issue 3/2014

Content (5 Articles)

Hypertension and Metabolic Syndrome (J Sowers and A Whaley-Connell, Section Editors)

Is There a Role for the Incretin System in Blood Pressure Regulation?

Akhilesh Rao, Ravi Nistala

Therapeutic Trials (B Pitt, Section Editor)

Should Patients with Obesity and Hypertension be Treated Differently from Those Who Are Not Obese?

Michael J. Bloch, Anthony J. Viera

Therapeutic Trials (B Pitt, Section Editor)

The Contribution of the ACCOMPLISH Trial to the Treatment of Stage 2 Hypertension

James Brian Byrd, George Bakris, Kenneth Jamerson

Mediators, Mechanisms, and Pathways in Tissue Injury (T Fujita, Section Editor)

ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury

Jasmina Varagic, Sarfaraz Ahmad, Sayaka Nagata, Carlos M. Ferrario

Pediatric Hypertension (J Flynn, Section Editor)

Late Hypertension in Patients with Repaired Aortic Coarctation

John O’Sullivan

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine